ATE415402T1 - Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen - Google Patents

Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen

Info

Publication number
ATE415402T1
ATE415402T1 AT03771620T AT03771620T ATE415402T1 AT E415402 T1 ATE415402 T1 AT E415402T1 AT 03771620 T AT03771620 T AT 03771620T AT 03771620 T AT03771620 T AT 03771620T AT E415402 T1 ATE415402 T1 AT E415402T1
Authority
AT
Austria
Prior art keywords
made therefrom
spengler reaction
compounds made
modified pictet
pictet
Prior art date
Application number
AT03771620T
Other languages
English (en)
Inventor
Mark Orme
Michael Martinelli
Christopher Doecke
Joseph Pawlak
Erik Chelius
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31191375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE415402(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Application granted granted Critical
Publication of ATE415402T1 publication Critical patent/ATE415402T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
AT03771620T 2002-07-31 2003-07-14 Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen ATE415402T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40038602P 2002-07-31 2002-07-31
US46016103P 2003-04-03 2003-04-03

Publications (1)

Publication Number Publication Date
ATE415402T1 true ATE415402T1 (de) 2008-12-15

Family

ID=31191375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03771620T ATE415402T1 (de) 2002-07-31 2003-07-14 Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen

Country Status (19)

Country Link
US (2) US7550479B2 (de)
EP (1) EP1546149B1 (de)
JP (2) JP2005536567A (de)
KR (1) KR100937915B1 (de)
CN (1) CN100430395C (de)
AT (1) ATE415402T1 (de)
AU (1) AU2003256539B2 (de)
BR (1) BR0313070B1 (de)
CA (1) CA2492540C (de)
DE (1) DE60324949D1 (de)
EA (1) EA008666B1 (de)
EG (1) EG23843A (de)
ES (1) ES2318175T3 (de)
IL (2) IL166255A (de)
MX (1) MXPA05001139A (de)
NO (1) NO331775B1 (de)
NZ (1) NZ537784A (de)
PL (1) PL216529B1 (de)
WO (1) WO2004011463A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116030A1 (en) * 2004-05-31 2005-12-08 Matrix Laboratories Ltd A process for the preparation of tadalafil
WO2006049986A1 (en) * 2004-10-28 2006-05-11 Dr. Reddy's Laboratories Ltd. Polymorphic forms of tadalafil
KR20070072891A (ko) * 2004-11-02 2007-07-06 테바 파마슈티컬 인더스트리즈 리미티드 타달라필 결정형 및 이의 제조 방법
EP1851222A1 (de) * 2005-02-25 2007-11-07 Teva Pharmaceutical Industries Ltd Verfahren zur synthetisierung von tadalafil
US20070004737A1 (en) * 2005-02-25 2007-01-04 Inbal Ornan Process of purifying tadalafil
KR20070099035A (ko) * 2005-02-25 2007-10-08 테바 파마슈티컬 인더스트리즈 리미티드 입도가 큰 타달라필 및 이의 제조 방법
KR20070110941A (ko) * 2005-04-12 2007-11-20 테바 파마슈티컬 인더스트리즈 리미티드 타달라필 중간체의 제조 방법
WO2007052283A1 (en) * 2005-10-31 2007-05-10 Alembic Limited An improved process for preparing tadalafil and its intermediate
EP2004644A1 (de) * 2006-03-24 2008-12-24 Glenmark Pharmaceuticals Limited Verfahren zur herstellung von tadalafil
KR101035742B1 (ko) * 2006-09-28 2011-05-20 신에쓰 가가꾸 고교 가부시끼가이샤 신규 광산 발생제 및 이것을 이용한 레지스트 재료 및 패턴형성 방법
US20080194529A1 (en) * 2007-02-12 2008-08-14 Auspex Pharmaceuticals, Inc. HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS
US8445698B2 (en) 2007-06-29 2013-05-21 Ranbaxy Laboratories Limited Process for the preparation of an intermediate of tadalafil
ITMI20080285A1 (it) 2008-02-22 2009-08-23 Endura Spa Procedimento per la preparazione di esteri di acidi tetraidro-1h-betacarbolin-3-carbossilici
EP2107059A1 (de) * 2008-03-31 2009-10-07 LEK Pharmaceuticals D.D. Umwandlung von Tryptophan in ß-Carbolinderivate
PL385356A1 (pl) * 2008-06-03 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania tadalafilu
CN101906103A (zh) * 2010-08-08 2010-12-08 浙江华海药业股份有限公司 四氢-β-咔啉化合物合成方法的改进
US8829023B2 (en) 2011-02-10 2014-09-09 Interquim, S.A. Process for obtaining compounds derived from tetrahydro-β-carboline
CN102367253B (zh) * 2011-09-20 2016-04-06 浙江华海药业股份有限公司 一种制备他达拉非晶型a的方法
AR099416A1 (es) 2014-02-28 2016-07-20 Lilly Co Eli Terapia combinada para la hipertensión resistente
CN103980275B (zh) * 2014-05-14 2016-09-28 湖北省医药工业研究院有限公司 磷酸二酯酶5抑制剂他达拉非的制备方法
CN104151313B (zh) * 2014-07-13 2019-04-09 浙江华海药业股份有限公司 一种纯化他达拉非中间体的方法
EP3172207B1 (de) * 2014-07-23 2019-03-06 KRKA, d.d., Novo mesto Verfahren zur herstellung des cgmp-phosphodiesterasehemmers und orale pharmazeutische formulierung mit tadalafil-co-präzipitaten
CN105842350B (zh) * 2015-05-14 2018-11-13 湖北生物医药产业技术研究院有限公司 利用高效液相色谱分析他达拉非合成中间体的方法
CN105061428B (zh) * 2015-08-26 2019-12-27 浙江华海药业股份有限公司 一种精制他达拉非的方法
CN106674223A (zh) * 2016-06-29 2017-05-17 浙江华海药业股份有限公司 一种精制他达拉非的方法
CN107663210A (zh) * 2016-07-28 2018-02-06 常州爱诺新睿医药技术有限公司 一种新的制备无水他达拉非晶型i的方法
CN106279155B (zh) * 2016-08-02 2019-03-19 扬子江药业集团四川海蓉药业有限公司 他达拉非的杂质对照品及其制备方法
CN109053724A (zh) * 2018-08-22 2018-12-21 上海青平药业有限公司 一种制备他达拉非过程中的杂质及该杂质的制备方法和他达拉非的纯化方法以及用途
CN110437228B (zh) * 2019-07-22 2022-06-14 山东省药学科学院 一种他达拉非及其中间体的制备方法
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers
CN110790764B (zh) * 2019-11-27 2021-04-06 四川省通园制药集团有限公司 一种一锅法制备他达拉非的方法
CN114057738A (zh) * 2021-12-14 2022-02-18 京博农化科技有限公司 一种氯吲哚酰肼的合成方法
CN114805345B (zh) * 2022-04-27 2023-11-10 山东省药学科学院 一种他达拉非中间体顺式四氢咔啉盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
MXPA03003971A (es) * 2000-11-06 2004-02-12 Lilly Icos Llc Derivados de indol como inhibidores de pde5.
WO2002098877A1 (en) * 2001-06-05 2002-12-12 Lilly Icos Llc Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives

Also Published As

Publication number Publication date
IL166255A (en) 2010-04-29
NO20051022L (no) 2005-04-22
KR100937915B1 (ko) 2010-01-21
JP4994427B2 (ja) 2012-08-08
AU2003256539A1 (en) 2004-02-16
BR0313070A (pt) 2005-06-28
ES2318175T3 (es) 2009-05-01
DE60324949D1 (de) 2009-01-08
CN100430395C (zh) 2008-11-05
NO331775B1 (no) 2012-03-26
CA2492540C (en) 2010-05-04
PL216529B1 (pl) 2014-04-30
US7550479B2 (en) 2009-06-23
CN1671706A (zh) 2005-09-21
EP1546149B1 (de) 2008-11-26
WO2004011463A1 (en) 2004-02-05
KR20050030961A (ko) 2005-03-31
IL200692A (en) 2011-11-30
EA200500264A1 (ru) 2005-08-25
CA2492540A1 (en) 2004-02-05
AU2003256539B2 (en) 2010-03-04
JP2009235096A (ja) 2009-10-15
EA008666B1 (ru) 2007-06-29
NZ537784A (en) 2008-01-31
BR0313070B1 (pt) 2014-09-09
IL166255A0 (en) 2006-01-15
MXPA05001139A (es) 2005-05-16
US20060004203A1 (en) 2006-01-05
EG23843A (en) 2007-10-17
JP2005536567A (ja) 2005-12-02
EP1546149A1 (de) 2005-06-29
PL375092A1 (en) 2005-11-14
IL200692A0 (en) 2010-05-17
US20090312548A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
ATE415402T1 (de) Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen
MXPA04000449A (es) Procedimiento para preparacion de derivados de amidina.
DE60330969D1 (de) Düsen und komponenten davon sowie herstellungsverfahren dafür
YU27304A (sh) Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova
EP1483281A4 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
NO20050929L (no) Fremgangsmater for fremstilling, isolering og rensing av epotilon B og rontgen krystallstrukturer av eptilon B
BRPI0507347B8 (de)
GEP20074230B (en) Phosphate prodrugs of fluorooxindoles
IL165988A0 (en) Process for the preparation of fibrinogen
ATE275153T1 (de) Antibiotika produzierende mikrobe
AU2002244906A1 (en) Formation of neolignan by ddq mediated dimerisation of dihydroasarone
MX2007003925A (es) Proceso para la preparacion de citalopram y escitalopram.
AU2003261327A1 (en) Base assemblies, methods of production and uses thereof
AU2003206926A8 (en) Cultivation method for micro-organisms and bioreactor
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
TW200504211A (en) New nitrile hydratase
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
HK1049026A1 (zh) L-薄荷醇的製備方法
EP1462108A4 (de) Mittel zur förderung der interferon-g (g)-produktion
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
BRPI0409074A (pt) processos de fermentação com baixas concentrações de nutrientes contendo carbono e nitrogênio
WO2005028985A3 (en) Cavitation reactor and method of producing heat
ATE374207T1 (de) Verfahren zur herstellung von lipid ii
TW200420533A (en) A process for the production of an aqueous solution of adipic acid, hydroxyhexanoic acid and oligomers thereof
ECSP055627A (es) Reacción modificada de pictet-spengler y productos preparados a partir de la misma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties